68Ga-NODAGA-LM3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-NODAGA-LM3, covering 2025-04-02 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors [Phase 1, Phase 2]